Sevenfact (Coagulation VIIA,Recomb-Jncw) Patent Expiration, LOE Window & CMS Spending

Sevenfact (Coagulation VIIA,Recomb-Jncw) by Lfb S.A Dba Hem: Off-Patent Genericized (AB Competition), 0 AB generics, $27.3M 2024 CMS Part D & Medicaid spend, and $5,320 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorLfb S.A Dba Hem
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$27.3M
2024 Medicare Part D Spend$0
2024 Medicaid Spend$27.3M
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($5,320 intro WAC)